Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
6.
Dermatologie (Heidelb) ; 74(6): 453-456, 2023 Jun.
Artigo em Alemão | MEDLINE | ID: mdl-36879141

RESUMO

Plexiform fibrohistiocytic tumors are rare, low-to-moderate malignant soft tissue tumors that occur primarily in children and adolescents and are located on the upper extremity. The diagnosis must be made histologically. We report on a young woman who presented a growing, painless lesion on the cubital fossa. Histopathology as well as the standard of treatment are discussed.


Assuntos
Histiocitoma Fibroso Benigno , Sarcoma , Neoplasias Cutâneas , Neoplasias de Tecidos Moles , Criança , Feminino , Adolescente , Humanos , Histiocitoma Fibroso Benigno/patologia , Neoplasias de Tecidos Moles/diagnóstico , Extremidade Superior/patologia
7.
Sci Rep ; 8(1): 7477, 2018 05 10.
Artigo em Inglês | MEDLINE | ID: mdl-29748622

RESUMO

A venous tumor thrombus (VTT) is a potentially lethal complication of renal cell carcinoma (RCC) but virtually nothing is known about the underlying natural history. Based on our observation that venous thrombi contain significant numbers of viable tumor cells, we applied multiregion whole exome sequencing to a total of 37 primary tumor and VTT samples including normal tissue specimens from five consecutive patients. Our findings demonstrate mutational heterogeneity between primary tumor and VTT with 106 of 483 genes (22%) harboring functional SNVs and/or indels altered in either primary tumor or thrombus. Reconstruction of the clonal phylogeny showed clustering of tumor samples and VTT samples, respectively, in the majority of tumors. However, no new subclones were detected suggesting that pre-existing subclones of the primary tumor drive VTT formation. Importantly, we found several lines of evidence for "BRCAness" in a subset of tumors. These included mutations in genes that confer "BRCAness", a mutational signature and an increase of small indels. Re-analysis of SNV calls from the TCGA KIRC-US cohort confirmed a high frequency of the "BRCAness" mutational signature AC3 in clear cell RCC. Our findings warrant further pre-clinical experiments and may lead to novel personalized therapies for RCC patients.


Assuntos
Carcinoma de Células Renais/genética , Neoplasias Renais/genética , Veias Renais/patologia , Transcriptoma , Trombose Venosa/genética , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células Renais/irrigação sanguínea , Carcinoma de Células Renais/complicações , Carcinoma de Células Renais/patologia , Estudos de Coortes , Análise Mutacional de DNA , Feminino , Regulação Neoplásica da Expressão Gênica , Genômica , Humanos , Neoplasias Renais/irrigação sanguínea , Neoplasias Renais/complicações , Neoplasias Renais/patologia , Masculino , Pessoa de Meia-Idade , Metástase Neoplásica , Trombose Venosa/complicações , Trombose Venosa/patologia , Sequenciamento do Exoma
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA